WallStSmart

Crown Castle (CCI)vsJanus Living, Inc. (JAN)

VS

Smart Verdict

WallStSmart Research — data-driven comparison

Crown Castle generates 543% more annual revenue ($4.21B vs $655.41M). CCI leads profitability with a 25.1% profit margin vs -0.0%. CCI earns a higher WallStSmart Score of 49/100 (D+).

CCI

Hold

49

out of 100

Grade: D+

Growth: 3.3Profit: 7.0Value: 4.0Quality: 4.5
Piotroski: 3/9Altman Z: -0.67

JAN

Avoid

32

out of 100

Grade: F

Growth: 8.0Profit: 3.0Value: 5.0Quality: 5.3
Piotroski: 4/9Altman Z: 1.64
IV

Intrinsic Value Comparison

Multi-model valuation · Graham Formula

CCISignificantly Overvalued (-29.8%)

Margin of Safety

-29.8%

Fair Value

$66.29

Current Price

$94.49

$28.20 premium

UndervaluedFair: $66.29Overvalued

Intrinsic value data unavailable for JAN.

Key Strengths & Concerns

Side-by-side fundamental analysis

Key Strengths

CCI3 strengths · Avg: 9.7/10
Operating MarginProfitability
47.7%10/10

Strong operational efficiency at 47.7%

Debt/EquityHealth
-12.8610/10

Conservative balance sheet, low leverage

Profit MarginProfitability
25.1%9/10

Keeps 25 of every $100 in revenue as profit

JAN2 strengths · Avg: 9.0/10
Revenue GrowthGrowth
34.5%10/10

Revenue surging 34.5% year-over-year

Price/BookValuation
2.2x8/10

Reasonable price relative to book value

Areas to Watch

CCI4 concerns · Avg: 2.8/10
P/E RatioValuation
38.9x4/10

Premium valuation, high expectations priced in

Piotroski F-ScoreQuality
3/93/10

Weak financial health signals

Return on EquityProfitability
-206.7%2/10

ROE of -206.7% — below average capital efficiency

Revenue GrowthGrowth
-4.8%2/10

Revenue declined 4.8%

JAN4 concerns · Avg: 3.3/10
EPS GrowthGrowth
0.0%4/10

0.0% earnings growth

Altman Z-ScoreHealth
1.644/10

Distress zone — elevated risk

Operating MarginProfitability
0.5%3/10

Operating margin of 0.5%

Return on EquityProfitability
-0.1%2/10

ROE of -0.1% — below average capital efficiency

Comparative Analysis Report

WallStSmart Research

Bull Case : CCI

The strongest argument for CCI centers on Operating Margin, Debt/Equity, Profit Margin. Profitability is solid with margins at 25.1% and operating margin at 47.7%.

Bull Case : JAN

The strongest argument for JAN centers on Revenue Growth, Price/Book. Revenue growth of 34.5% demonstrates continued momentum.

Bear Case : CCI

The primary concerns for CCI are P/E Ratio, Piotroski F-Score, Return on Equity.

Bear Case : JAN

The primary concerns for JAN are EPS Growth, Altman Z-Score, Operating Margin.

Key Dynamics to Monitor

CCI profiles as a declining stock while JAN is a hypergrowth play — different risk/reward profiles.

JAN is growing revenue faster at 34.5% — sustainability is the question.

CCI generates stronger free cash flow (452M), providing more financial flexibility.

Monitor REIT - SPECIALTY industry trends, competitive dynamics, and regulatory changes.

Bottom Line

CCI scores higher overall (49/100 vs 32/100), backed by strong 25.1% margins. Both earn "Hold" and "Avoid" ratings respectively — the choice depends on your investment horizon and risk tolerance.

This analysis is generated from publicly available financial data. Not financial advice.

Crown Castle

REAL ESTATE · REIT - SPECIALTY · USA

Crown Castle is a real estate investment trust and provider of shared communications infrastructure in the United States. Its network includes over 40,000 cell towers and nearly 80,000 route miles of fiber supporting small cells and fiber solutions. Headquartered in Houston, Texas, the company has 100 offices nationwide.

Visit Website →

Janus Living, Inc.

REAL ESTATE · REIT - RESIDENTIAL · USA

JanOne Inc., a clinical-stage biopharmaceutical company, focuses on identifying, acquiring, licensing, developing, partnering, and commercializing novel, non-opioid, and non-addictive therapies to address the unmet medical need for pain management. The company is headquartered in Las Vegas, Nevada.

Want to dig deeper into these stocks?